Cargando…
Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany
Biologic drugs represent a large and growing portion of health expenditures. Increasing the use of biosimilars is a promising option for controlling spending growth in pharmaceutical care. Amid the considerable uncertainty concerning physicians’ decision to prescribe biosimilars, explicit cost contr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313006/ https://www.ncbi.nlm.nih.gov/pubmed/32526943 http://dx.doi.org/10.3390/ijerph17114113 |